VFEND
Pfizer Ireland Pharmaceuticals
| Research |
OneLook
Acronym Finder
|
| Serial Number | 78469910 |
| Registration Number | 3017665 |
| Mark Drawing Code | 3000: Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) |
| Domestic Representative | Christopher Bolinger |
| Attorney Name | Janina Gorbach |
| Attorney Docket Number | T191235 |
| Law Office Assigned | M70 |
| Employee Name | AWRICH, ELLEN |
Timeline
| 2002-08-04 | Date of First Use |
| 2004-08-19 | Application Filed |
| 2005-08-30 | Published for Opposition |
| 2005-11-22 | Trademark Registered |
| 2015-11-22 | Renewal Date |
| 2015-12-30 | Location: GENERIC WEB UPDATE |
| 2015-12-30 | Status: Live/Registered |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  PFIZER IRELAND PHARMACEUTICALS |
| Entity Statement | PRIVATE UNLIMITED LIABILITY COMPANY INCORPORATED IN IRELAND |
| Address | OPERATIONS SUPPORT GROUP RINGASKIDDY COUNTY CORK IE |
| Legal Entity Type | |
| Legal Entity State | IE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Design Search Codes
| 260121 | Circles that are totally or partially shaded. |
| 261709 | Bands, curved; Bars, curved; Curved line(s), band(s) or bar(s); Lines, curved |
Attorney of Record
Good, Services, and Codes
| International Codes: | 16 |
| U.S. Codes: | 002,005,022,023,029,037,038,050 |
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| CC0000 | Color is not claimed as a feature of the mark. |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2004-08-26 | 1 NWAP I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2005-03-22 | 2 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2005-03-22 | 3 CNRT R:Renewal |
| NON-FINAL ACTION MAILED | 2005-03-23 | 4 CNRT F:First Action |
| PAPER RECEIVED | 2005-04-19 | 5 MAIL I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2005-04-19 | 6 CRFA I:Incoming Correspondence |
| AMENDMENT FROM APPLICANT ENTERED | 2005-04-26 | 7 ACEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2005-04-27 | 8 CNSA O:Outgoing Correspondence |
| ASSIGNED TO LIE | 2005-04-29 | 9 ALIE A:Allowance for Publication |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2005-05-05 | 10 PREV O:Outgoing Correspondence |
| NOTICE OF PUBLICATION | 2005-08-10 | 11 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2005-08-30 | 12 PUBO A:Allowance for Publication |
| REGISTERED-PRINCIPAL REGISTER | 2005-11-22 | 13 R.PR A:Allowance for Publication |
| AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2011-04-20 | 14 ASGN I:Incoming Correspondence |
| TEAS SECTION 8 & 15 RECEIVED | 2012-04-13 | 15 E815 I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2012-04-13 | 16 TCCA I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2012-04-30 | 17 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | 2012-04-30 | 18 C15A O:Outgoing Correspondence |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | 2012-04-30 | 19 NA85 E:E-Mail |
| TEAS SECTION 8 & 9 RECEIVED | 2015-10-23 | 20 E89R I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2015-12-30 | 21 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | 2015-12-30 | 22 89AG O:Outgoing Correspondence |
| REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | 2015-12-30 | 23 RNL1 Q: |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | 2015-12-30 | 24 NA89 E:E-Mail |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 VFEND 78469910 3017665 Live/Registered |
PFIZER IRELAND PHARMACEUTICALS 2004-08-19 |
 VFEND 76269065 not registered Dead/Abandoned |
Pfizer Inc. 2001-06-07 |
 VFEND 75122046 2455588 Live/Registered |
PFIZER IRELAND PHARMACEUTICALS 1996-06-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 